Drugs and Diagnostics for Hematological Disorders: Global Markets

NEW YORK, March 12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Drugs and Diagnostics for Hematological Disorders: Global Markets

http://www.reportlinker.com/p01119541/Drugs-and-Diagnostics-for-Hematological-Disorders-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

INTRODUCTION

STUDY GOALS AND OBJECTIVES

This BCC market research report will increase the awareness of current and emerging drugs and technologies for hematological disorders and blood cancers, including hematological disorder therapeutics, chemotherapy, radiation therapy, surgical therapy, immunotherapy and also nutrition therapy.

INTENDED AUDIENCE

This report is an exhaustive study on the global hematological disorders and blood cancer market, with important statistics and analysis on existing drugs and diagnostic technologies, latest trends, market structure, market size, key drug segments and trends in technology. This study contributes to the areas of market growth in hematological disorders and blood cancer prevention and treatment strategies from the point of view of manufacturers, product suppliers, healthcare providers, and consumers of hematological disorder and cancer products and services. This study will be of interest largely to the pharmaceutical and biotechnology industries, as well as clinics, hospitals and research institutes. This report may also prove crucial for investment firms in the concerned sector. This report shows tests currently being used for hematological disorders and cancer diagnosis and prognosis, new developments, spending trends and revenue prospects for these technologies. The report provides market data for 2010 to 2017 and also covers commercial prospects for hematological disorders and cancer diagnostic assays, current tests in use and their future.

SCOPE OF THE STUDY

The scope of this study is testing, screening technology and also therapeutics markets for hematological disorders and blood cancers. The report also includes the regulatory environment, current technologies, new technologies, hematological disorders and cancer incidence, market projections and market share, along with latest trends and new developments.

Read the original post:
Drugs and Diagnostics for Hematological Disorders: Global Markets